GLENMARK LIFE SCIENCES LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 822.6 INR | -1.37% |
|
-0.63% | +25.19% |
| May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| Apr. 25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
Evolution of the average Target Price on Glenmark Life Sciences Limited
Price target over the last 5 years
History of analyst recommendation changes
366f70c322dfe14a0ae0e7f5b5ee.e9Du-daZio7b5Ls_ki-INoSgyPsCRLC_1vOw3z2h01A.Q6WNkIb8_LuE0ox760LyRcfMrZptPsWHt6zn7Qz54SAP5Juco6j_743R_g~b146b6ae60087f4df7d1a5a1a01dcf69
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
822.6
INR
Average target price
905.8
INR
Spread / Average Target
+10.11%
High Price Target
993
INR
Spread / Highest target
+20.72%
Low Price Target
790
INR
Spread / Lowest Target
-3.96%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D
EPS Revisions
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- GLS Stock
- Consensus Glenmark Life Sciences Limited
